AsCNP/JSNP/JSCNP 2019

Presentation information

[NP] Oral Session

NP » [NP] Oral Session

[NP_O2] Oral Session 2

Sat. Oct 12, 2019 10:30 AM - 12:10 PM Room 8 (404)

座長:奥川  学(関西記念病院)、池田 和仁(大日本住友製薬株式会社)

11:35 AM - 11:48 AM

[NP-O2-6] Association of clozapine therapy with antipsychotic monotherapy in schizophrenia revealed from the results of prescription study of the EGUIDE project

Naomi HASEGAWA1, Yota UNO1, Yuka YASUDA1, 2, Yamamoto TOMOYA3, Koichiro WATANABE4, Ken INADA5, Ryota HASHIMOTO1, 6 (1. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Life Grow Brilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan, 3. Department of Pharmacy,Osaka University Hospital, Osaka, Japan, 4. Department of Neuropsychiatry, Kyorin University School of Medicine , Tokyo, Japan, 5. Department of Psychiatry, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan, 6. Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password